Regaine for Women, Hair Growth & Prevents further Hair Loss, Scalp Foam, with Minoxidil, 4 Months’ Supply , 2 x 73ml

Product Information

A dose of 1 ml Regaine for Women Regular Strength cutaneous solution should be applied to the total affected areas of the scalp twice daily. The effect of Regaine for Women Regular Strength has been assessed in phase III clinical trials in women conducted over a 48 week treatment period.

Women who have any problems with the skin on the scalp, including psoriasis, eczema, sunburn or broken skin. Before using Regaine for Women Regular Strength, the user should determine that the scalp is normal and healthy. Hair growth may be soft and downy at the start but should eventually become the same as normal hair. If you have hair loss that you find difficult to cover up (around 50% hair loss or more), or your hair loss is a result of cancer treatment, you may be eligible for a wig on the NHS. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.Sex is determined by chromosomes, and gender is a social construct that can vary between time periods and cultures.

There is a potential risk that minoxidil, the active ingredient in Regaine for Women Regular Strength, may interact with these medicines and increase their effect. Patients with known cardiovascular disease or cardiac arrhythmia should contact a physician before using Regaine for Women Regular Strength.The study also found that the participants who used the 5% topical minoxidil had improved “psychosocial perceptions” of hair loss.

While it can take up to 4 months to see hair regrowth with Rogaine, the product may start working within 2 weeks. Losing your hair as a woman, especially if you're young or at a vulnerable time in your life, can badly affect your confidence.It penetrates the root to help stop hair thinning, reactivates inactive follicles, whilst strengthening and revitalising the hair follicle to grow new, thicker hair.